Article 30 Apr 2024 Red Alert On The Orange Book: The FTC Continues To Crack Down On Improperly Listed Drug Patents United States IP
Article 22 Apr 2024 Maryland And Colorado Say The Price Isn't Right: State Drug Affordability Review Boards Seek Drug Upper Payment Limits United States Healthcare
Article 19 Jan 2024 Throwing The (Orange) Book At Pharmaceutical Manufacturers: FTC Challenges Over 100 Drug Product Patents Listed In FDA Publication United States Healthcare